| Sep 12 |
Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
|
| Sep 4 |
Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 27 |
Monopar regains compliance with Nasdaq minimum bid price rule
|
| Aug 27 |
Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
|
| Aug 21 |
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
|
| Aug 14 |
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
|
| Aug 12 |
Upcoming Stock Splits This Week (August 12 to August 16) – Stay Invested
|
| Aug 9 |
Monopar Therapeutics to implement 1-for-5 reverse stock split
|
| Aug 9 |
Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
|
| Aug 9 |
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
|
